WNT6/ACC2-induced storage of triacylglycerols in macrophages is exploited by Mycobacterium tuberculosis
Authors:
- Julius BrandenburgJBJulius Brandenburg
- Sebastian MarwitzSMSebastian Marwitz
- Simone C. TazollSTSimone C. Tazoll
- Franziska WaldowFWFranziska Waldow
- Barbara KalsdorfBKBarbara Kalsdorf
- Tim VierbuchenTVTim Vierbuchen
- Thomas ScholzenTSThomas Scholzen
- Annette GrossAGAnnette Gross
- Svenja GoldenbaumSGSvenja Goldenbaum
- Alexandra HölscherAHAlexandra Hölscher
- Martina HeinMHMartina Hein
- Lara LinnemannLLLara Linnemann
- 16 August 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 131 (16)
Abstract
In view of emerging drug-resistant tuberculosis (TB), host-directed adjunct therapies are urgently needed to improve treatment outcomes with currently available anti-TB therapies. One approach is to interfere with the formation of lipid-laden “foamy” macrophages in the host, as they provide a nutrient-rich host cell environment for Mycobacterium tuberculosis (Mtb). Here, we provide evidence that Wnt family member 6 (WNT6), a ligand of the evolutionarily conserved Wingless/Integrase 1 (WNT) signaling pathway, promotes foam cell formation by regulating key lipid metabolic genes including acetyl-CoA carboxylase 2 (ACC2) during pulmonary TB. Using genetic and pharmacological approaches, we demonstrated that lack of functional WNT6 or ACC2 significantly reduced intracellular triacylglycerol (TAG) levels and Mtb survival in macrophages. Moreover, treatment of Mtb-infected mice with a combination of a pharmacological ACC2 inhibitor and the anti-TB drug isoniazid (INH) reduced lung TAG and cytokine levels, as well as lung weights, compared with treatment with INH alone. This combination also reduced Mtb bacterial numbers and the size of mononuclear cell infiltrates in livers of infected mice. In summary, our findings demonstrate that Mtb exploits WNT6/ACC2-induced storage of TAGs in macrophages to facilitate its intracellular survival, a finding that opens new perspectives for host-directed adjunctive treatment of pulmonary TB.Keywords
Funding Information
- DFG
- DFG (Priority program SPP 1580 Re12285-1 Re12285-2)
- Deutsches Zentrum für Infektionsforschung (TTU-TB TTU02.705)
- Deutsches Zentrum für Infektionsforschung (TTU-TB TTU 02.806,TTU-TB TTU02.810)
- Deutsches Zentrum für Infektionsforschung (TTU-TB TTU02.704-1 TTU02.811)
This publication has 81 references indexed in Scilit:
- A new in vivo model to test anti-tuberculosis drugs using fluorescence imagingJournal of Antimicrobial Chemotherapy, 2012
- The enzymology of mitochondrial fatty acid beta‐oxidation and its application to follow‐up analysis of positive neonatal screening resultsJournal of Inherited Metabolic Disease, 2010
- Foamy macrophages and the progression of the human tuberculosis granulomaNature Immunology, 2009
- TIP47 functions in the biogenesis of lipid dropletsJournal of Cell Biology, 2009
- The Isolation and Characterization of Murine MacrophagesCurrent Protocols in Immunology, 2008
- Identification of outer membrane proteins of Mycobacterium tuberculosisTuberculosis, 2008
- Standardization of real-time PCR gene expression data from independent biological replicatesAnalytical Biochemistry, 2008
- Mycobacterial persistence requires the utilization of host cholesterolProceedings of the National Academy of Sciences, 2008
- Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivityProceedings of the National Academy of Sciences, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005